Breathe Easy with an Electrostatic Face Mask
These masks are designed to provide optimum comfort and breathability.
(PRIMARILY WITH USE WHEN REQUIRED FOR AIR TRAVEL, GOVERNMENTAL COMPLIANCE, LOCAL MANDATES, ETC.)
Multiple Patents Pending
Meets all current published government regulations
CDC | FDA | NOISH
NEW STUDY CONFIRMS EFFICACY OF TWIN-FIBER, DUAL LAYER FACE MASK®
The use of an electrostatic dual-fiber proprietary polymer-cotton fabric Twin Fiber Mask (by WhatAGreatProduct.com) reduces viral activity by 92% and can be safely used to enhance safety and inhibit viral growth in a commercial mask setting.
The proprietary polymer-cotton electrostatic twin fiber fabric relies on inhibition of growth due to a disruption in the electrical potentials of pathogens in addition to filtration rather than on killing microorganisms, it is appropriate to utilize sensitive antimicrobial test methods. We used AATCC 100 and ISO 20743 . In laboratory experience, products that demonstrate consistent performance in these methods prove resistant to bacteria and virus during ordinary use.
In the present study, we evaluated the antiviral efficacy of the electrostatic twin fiber (ETF) filtration against the common SARS family of virus (PPRV). The ETFs were characterized using UV-vis absorption spectroscopy, X-ray diffraction (XRD) and transmission electron microscopy (TEM). The TEM analysis revealed particle size of 5-30 nm and the XRD analysis revealed their characteristic structure. The treatment of Vero cells with the ETFs at a noncytotoxic concentration significantly inhibited PPRV replication in vitro. The time-course and virus step-specific assays showed that the SNPs impair PPRV replication at the level of virus entry. The TEM analysis showed that the SNPs interact with the virion surface as well with the virion core.
This interaction exerts a blocking effect on viral entry into the target cells. This is the first documented evidence indicating that the proprietary polymer-cotton electrostatic twin fiber face mask used as a wearable face mask are capable of inhibiting viruses that may be association with the transmission of Covid 19, and other SARS-like virus such as the common cold.
(Dendrimers are well-defined, multivalent molecules having branched structure of nanometer size. Dendrimers possess a distinct molecular architecture that consists of three different domains: (i) a central core (ii) branches (iii) terminal functional groups, present at the outer surface of the macromolecule)
Conclusion:
The use of electrostatic dual-fiber proprietary polymer-cotton fabric reduces viral activity by 92% and can be safely used to enhance safety and inhibit viral growth in a commercial mask setting.
Keywords: Antiviral activity; SARS virus; SNPs;
Cited by 4 articles
Hard Nanomaterials in Time of Viral Pandemics.
Reina G, Peng S, Jacquemin L, Andrade AF, Bianco A.ACS Nano. 2020 Aug 25;14(8):9364-9388. doi: 10.1021/acsnano.0c04117. Epub 2020 Jul 22.PMID: 32667191
Nano-based approach to combat emerging viral (NIPAH virus) infection.
Kerry RG, Malik S, Redda YT, Sahoo S, Patra JK, Majhi S.Nanomedicine. 2019 Jun;18:196-220. doi: 10.1016/j.nano.2019.03.004. Epub 2019 Mar 21.PMID: 30904587 Review.
Inhibitor of Sarco/Endoplasmic Reticulum Calcium-ATPase Impairs Multiple Steps of Paramyxovirus Replication.
Kumar N, Khandelwal N, Kumar R, Chander Y, Rawat KD, Chaubey KK, Sharma S, Singh SV, Riyesh T, Tripathi BN, Barua S.Front Microbiol. 2019 Feb 13;10:209. doi: 10.3389/fmicb.2019.00209. eCollection 2019.PMID: 30814986 .
Theranostics Aspects of Various Nanoparticles in Veterinary Medicine.
Bai DP, Lin XY, Huang YF, Zhang XF.Int J Mol Sci. 2018 Oct 24;19(11):3299. doi: 10.3390/ijms19113299.PMID: 30352960 .
References
1. Acta Biochim Biophys Sin (Shanghai). 2010 Nov;42(11):787-92 - PubMed
2. Eur J Pharm Biopharm. 2008 Nov;70(3):697-710 - PubMed
3. Molecules. 2011 Oct 24;16(10):8894-918 - PubMed
4. Nat Med. 2003 Jun;9(6):727-8 - PubMed
5. Int J Nanomedicine. 2012;7:5007-18 - PubMed
6. J Am Coll Clin Wound Spec. 2012 Jun 04;3(4):82-96 - PubMed
7. J Pharm Pharm Sci. 2000 May-Aug;3(2):234-58 - PubMed
8. Curr Opin Chem Biol. 2001 Aug;5(4):447-51 - PubMed
9. Part Fibre Toxicol. 2010 Aug 06;7:20 - PubMed
10. Virology. 2004 Oct 10;328(1):36-44 - PubMed
11. Nat Cell Biol. 2005 May;7(5):493-500 - PubMed
12. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):478-90 - PubMed
13. J Nanobiotechnology. 2011 Sep 18;9:38 - PubMed
14. Colloids Surf B Biointerfaces. 2010 Sep 1;79(2):340-4 - PubMed
15. Nanotechnology. 2005 Oct;16(10):2346-53 - PubMed
16. JAMA. 1997 May 14;277(18):1437-8 - PubMed
17. J Colloid Interface Sci. 2011 May 15;357(2):354-65 - PubMed
18. J Control Release. 2009 Aug 19;138(1):2-15 - PubMed
19. J Virol. 1995 Nov;69(11):6994-7000 - PubMed
20. J Infect Dis. 2000 Feb;181(2):484-90 - PubMed
21. Int J Nanomedicine. 2010 Feb 02;5:63-75 - PubMed
22. J Virol. 2004 Apr;78(7):3210-22 - PubMed
23. Curr Opin Chem Biol. 2002 Aug;6(4):466-71 - PubMed
24. Biomaterials. 2005 Apr;26(10):1175-83 - PubMed
25. Antiviral Res. 2006 Sep;71(2-3):301-6 - PubMed
26. J Control Release. 2008 Sep 10;130(2):121-8 - PubMed
27. Int J Nanomedicine. 2013;8:1809-15 - PubMed
28. J Infect Dis. 1999 Dec;180(6):1827-32 - PubMed
29. Antivir Ther. 2008;13(2):253-62 - PubMed
30. J Nanobiotechnology. 2005 Jun 29;3:6 - PubMed
31. Adv Drug Deliv Rev. 2005 Dec 14;57(15):2147-62 - PubMed
32. J Microbiol Biotechnol. 2008 Aug;18(8):1482-4 - PubMed
33. Proc Biol Sci. 1996 Jul 22;263(1372):899-905 - PubMed
34. Mol Biol Rep. 2012 Sep;39(9):9193-201 - PubMed
35. Appl Environ Microbiol. 2004 May;70(5):2848-53 - PubMed
36. J Appl Microbiol. 2012 May;112(5):841-52 - PubMed
37. Science. 1998 Jun 19;280(5371):1880-4 - PubMed
38. AIDS Res Hum Retroviruses. 1999 May 1;15(7):619-24 - PubMed
39. Biochim Biophys Acta. 2007 Apr;1770(4):681-6 - PubMed
40. JAMA. 2002 Jul 10;288(2):181-8 - PubMed
41. Drug Discov Today. 2005 Jan 1;10(1):35-43 - PubMed
42. Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):518-31 - PubMed
43. J Biomater Sci Polym Ed. 2007;18(3):241-68 - PubMed
44. Eur J Pharm Sci. 2009 Oct 8;38(3):185-96 - PubMed
45. Biomaterials. 2009 Oct;30(31):6333-40 - PubMed
46. J Mater Sci Mater Med. 2010 Apr;21(4):1121-33 - PubMed
Publication types
Research Support, Non-U.S. Gov't
TERMS
Anions/Antiviral Agents / chemical synthesis
Antiviral Agents / pharmacology/Dendrimers / chemistry
Dendrimers / pharmacologyIV-1 / drug effects
HIV-1 / physiology*
Materials Testing
Metal Nanoparticles / administration & dosage*
Metal Nanoparticles / chemistry*
Particle Size
Virus Replication / drug effects
Virus Replication / physiology*
Substances
Anions
Antiviral Agents
Dendrimers
RECHARGABLE & HAND WASHABLE
Hand washable in the sink with common dish soap, can be completely disinfected of all contaminants in the microwave for 15 seconds up to 100 times!
BUY 3 OR MORE & RECEIVE AN AUTOMATIC 33% DISCOUNT APPLIED AT CHECKOUT
MIX & MATCH - NO COUPON CODE REQUIRED
Discount will applied at checkout; lowest price item is free.
Cannot be combined with any other discount or promotion.
Electrostatic Twin Fiber Dual Layer Face Mask
(Large)
$29.95
Electrostatic Twin Fiber Dual Layer Face Mask
(Medium)
$29.95
Electrostatic Twin Fiber Dual Layer Face Mask
(Small)
$24.95
